Shield Therapeutics (STX) Stock Chart & Stock Price History GBX 3.66 -0.14 (-3.55%) As of 02/21/2025 11:24 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Shield Therapeutics Stock Price Performance 5 Day Performance-1.11%1 Month Performance+49.78%3 Month Performance+28.60%6 Month Performance+8.11%Year-To-Date Performance+35.74%1 Year Performance+24.66% Receive STX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address STX Stock Chart for Saturday, February, 22, 2025 STX Chart by TradingView Shield Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 3.70GBX 3.67-1.03%GBX 3.80GBX 3.531.22 million shs£36.17 million02/20/2025GBX 3.70GBX 3.70+0.08%GBX 3.90GBX 3.701.30 million shs£36.54 million02/19/2025GBX 3.61GBX 3.70+2.49%GBX 3.95GBX 3.604.00 million shs£36.51 million02/18/2025GBX 3.71GBX 3.61-2.59%GBX 3.85GBX 3.60941,301 shs£35.63 million02/17/2025GBX 4.14GBX 3.71-10.42%GBX 4.20GBX 3.702.04 million shs£36.57 million02/14/2025GBX 3.80GBX 4.14+8.87%GBX 4.20GBX 3.803.50 million shs£40.83 million02/13/2025GBX 3.87GBX 3.80-1.81%GBX 4.10GBX 3.605.37 million shs£37.50 million02/12/2025GBX 3.70GBX 3.87+4.59%GBX 4GBX 3.613.42 million shs£30.27 million02/11/2025GBX 3.46GBX 3.70+6.87%GBX 3.90GBX 3.508.95 million shs£28.94 million02/10/2025GBX 2.93GBX 3.46+18.16%GBX 3.58GBX 2.957.01 million shs£27.08 million Get the Latest News and Ratings for STX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 3.01GBX 2.93-2.66%GBX 3.06GBX 2.932.55 million shs£22.91 million02/06/2025GBX 3.38GBX 3.01-10.95%GBX 3.60GBX 33.89 million shs£23.54 million02/05/2025GBX 2.88GBX 3.38+17.36%GBX 3.70GBX 3.2914.24 million shs£26.43 million02/04/2025GBX 2.68GBX 2.88+7.46%GBX 2.88GBX 2.702.17 million shs£22.52 million02/03/2025GBX 2.80GBX 2.68-4.29%GBX 2.80GBX 2.66266,236 shs£20.96 million01/31/2025GBX 2.70GBX 2.80+3.70%GBX 2.80GBX 2.601.74 million shs£21.90 million01/30/2025GBX 2.62GBX 2.70+3.05%GBX 2.80GBX 2.64315,305 shs£21.12 million01/29/2025GBX 2.87GBX 2.62-8.65%GBX 3GBX 2.621.45 million shs£20.49 million01/28/2025GBX 2.90GBX 2.87-0.97%GBX 3GBX 2.86712,089 shs£22.43 million01/27/2025GBX 3GBX 2.90-3.47%GBX 3.10GBX 2.801.21 million shs£22.65 million01/24/2025GBX 2.81GBX 3+6.76%GBX 3.10GBX 2.804.42 million shs£23.46 million01/23/2025GBX 2.45GBX 2.81+14.83%GBX 2.86GBX 2.417.95 million shs£21.98 million01/22/2025GBX 2.35GBX 2.45+4.13%GBX 2.45GBX 2.361.89 million shs£19.14 million01/21/2025GBX 2.35GBX 2.35GBX 2.40GBX 2.33391,424 shs£18.38 million Related Companies STK Stock Chart DGI Stock Chart VLG Stock Chart EAH Stock Chart PXS Stock Chart CEL Stock Chart RGT Stock Chart N4P Stock Chart HELD Stock Chart HLN Stock Chart Receive STX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:STX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shield Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
